Contribute Try STAT+ Today

Good morning, everyone, and welcome to another working week. We hope the weekend respite — which was extended, in our case — was refreshing and invigorating, because the predictable routine of online meetings, calls, and deadlines has returned. But what can you do? After all, the world keeps spinning, despite what conspiracy theorists may say. So time to get cracking and fire up the coffee kettle. Meanwhile, here are a few tidbits to help you get oriented. We hope your day is productive and you conquer the world. And do stay in touch. …

Pfizer (PFE) and Moderna (MRNA) raised the prices of their Covid-19 vaccines in their latest European Union supply contracts, The Financial Times reports. The new price for the Pfizer shot was $23.15 compared with $18.39. The price of a Moderna vaccine was $25.50 a dose, the contracts show, up from about $22.50 in the first procurement deal, but lower than the previously agreed $28.50 because the order had grown. Last week, Pfizer raised its forecast for sales of its Covid-19 vaccine this year to about $33.5 billion, a nearly 30% increase.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment